BioRestorative Therapies appoints David Jenkins to board
BRTX•BioRestorative Therapies appointed David Jenkins to its four-member board on November 10, 2026, filling a vacancy left by Jatinder Dhaliwal. Jenkins will chair two committees and join the audit committee; Esha Randhawa and Dhaliwal resigned from the board earlier in November.
1. Board changes
BioRestorative Therapies appointed David Jenkins to its four-member board on November 10, 2026, filling the vacancy left by Jatinder Dhaliwal. Jenkins will chair the compensation and nominating and corporate governance committees and join the audit committee. Esha Randhawa resigned from the board and its committees effective November 5, while Dhaliwal departed those roles effective November 6. Donald J. Currie, a director since October 2026, also joined the audit committee.
2. Jenkins’ experience
Jenkins has been an Akanda director since February 2023 and served as interim CEO and interim CFO of Kiaro Holdings from 2023 to 2025.
